| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,436 |
4,082 |
$151K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
662 |
643 |
$31K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
660 |
628 |
$30K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
593 |
537 |
$18K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,028 |
919 |
$16K |
| 87428 |
|
88 |
88 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
157 |
152 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
59 |
57 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
66 |
58 |
$2K |
| 87807 |
|
119 |
115 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
22 |
21 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
13 |
$934.18 |
| 81002 |
|
206 |
190 |
$525.20 |
| 81025 |
|
79 |
73 |
$421.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
20 |
15 |
$19.32 |